Moderna Vaccine

A study from the US Centers for Disease Control and Prevention (CDC) has shown that both BioNTech-Pfizer and Moderna vaccines are 90% effective at preventing infections, including asymptomatic infections, with the first dose showing 80% efficacy.

“Reducing the risk for transmissible infection, which can occur among persons with asymptomatic infection or among persons several days before symptoms onset, is especially important among health care personnel, first responders, and other essential and frontline workers given their potential to transmit the virus through frequent close contact with patients and the public,” the report concluded.

After her mother was vaccinated against Covid-19, a baby girl was born with antibodies that fight the coronavirus in Florida in the eastern United States.

The girl's mother was 36 weeks pregnant when she received the first dose of the antidote developed by the Moderna laboratory, to which she agreed because she was on the front line of the fight against the pandemic. The baby girl was born three weeks later, in late January.

"As far as we know, this is the world's first reported case of a baby born with covid-19 antibodies after her mother's vaccination," said Paul Gilbert, a pediatrician. Gilbert and Chad Rudnick, also a pediatrician, will publish a scientific paper on the matter, they said in an interview with Palm Beach television station WBPF.

Because a refrigerator at a hospital-owned by the Kaiser Permanente hospital group broke and the vaccine doses from manufacturer Moderna apparently could not be stored elsewhere, the active ingredients had to be administered quickly. "We had twelve hours to get those 1600 doses out to people," a company spokeswoman said in a virtual press conference Friday morning.

Health Canada has authorized Moderna's Covid-19 vaccine on December 23.

"Today’s authorization is a critical step in ensuring additional COVID-19 vaccines are available to all Canadians in all parts of the country, Health Canada said in a statement," so the statement. "The different storage and handling requirements of the Moderna COVID-19 vaccine mean that it can be distributed to isolated and remote communities, including the territories."

According to Moderna, the pharmaceutical company will submit its application for conditional market authorization for its new Covid-19 to the European Medicines Agency Ema on Monday.

The EU Commission has already secured up to 160 million doses of the vaccination according to EU Commission President Ursula von der Leyen.

The US and Europe may grant emergency authorisation for Pfizer and BioNTech's Covid-19 vaccine in early December after final trial results showed a 95% success rate and no serious side effects. Moderna's vaccine has also shown a 94.5% effectiveness.

Spain has announced to begin a comprehensive vaccination programme in January and hope to cover a substantial part of the population within three months, so prime minister, Pedro Sanchez.